Bevacizumab (Avastin) inhibits lung cancer-induced pulmonary microvascular angiogenesis / 南方医科大学学报
Journal of Southern Medical University
;
(12): 1027-1043, 2006.
Article
in Chinese
| WPRIM
| ID: wpr-335001
ABSTRACT
<p><b>OBJECTIVE</b>To study the effect of bevacizumab (Avastin) on pulmonary microvascular angiogenesis induced by lung cancer.</p><p><b>METHODS</b>The effects of Avastin on cell growth, cell cycle and apoptosis of lung microvascular endothelial cells were assayed by flow cytometry.</p><p><b>RESULTS</b>Avastin inhibited the growth of lung microvascular endothelial cells and induced increase of cell apoptosis index in a concentration-dependent manner. With the increment of Avastin concentration from 25 to 100 microg/ml, avascular area increased from 0.944-/+0.073 cm square to 5.189-/+0.192 cm square, and the cell apoptosis index increased from 32.5%-/+1.5% to 39.25-/+1.6%.</p><p><b>CONCLUSION</b>Avastin can inhibit the growth and induce apoptosis of lung microvascular endothelial cells in three-dimensional culture, possibly in association with cell cycle arrest in G(0/1) phase.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Pharmacology
/
Capillaries
/
Adenocarcinoma
/
Cell Cycle
/
Cells, Cultured
/
Apoptosis
/
Angiogenesis Inhibitors
/
Cell Line, Tumor
/
Endothelial Cells
Limits:
Animals
/
Humans
Language:
Chinese
Journal:
Journal of Southern Medical University
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS